Peer Review

Normal-Tension Glaucoma: Diagnosis and Treatment

Arpine Barsegian, MD

Peer Review

Normal-Tension Glaucoma: Pathogenesis

The first in a two-part series on this multifactorial disease subtype.

Arpine Barsegian, MD

Peer Review

Glaucoma Filtering Surgeries

Evidence to consider when comparing traditional and modern approaches.

Leonard K. Seibold, MD

Peer Review

An Update on Standard Automated Perimetry

A review of progression analysis and testing algorithms and a look ahead at future technologies.

Astrid Werner, MD

Peer Review

Management of Ocular Surface Disease Before and After Glaucoma Surgery

OSD in patients who have glaucoma is best managed with a methodical, proactive approach to diagnosis and treatment.

Laura A. Voicu, MD

Peer Review

Safety and Efficacy Outcomes of Low-Cost Glaucoma Drainage Implants

Two novel devices expand the options for surgical glaucoma treatment on a global level.

Ahmad A. Aref, MD, MBA

Peer Review

MIGS in Kids

Advances in the adult microinvasive surgical space are affecting the management of primary congenital glaucoma, but pediatric patients remain an afterthought.

James D. Brandt, MD

Peer Review

Home-Based Glaucoma Monitoring

Tools for expanding glaucoma diagnosis and management beyond the office.

Kateki Vinod, MD, and Sarwat Salim, MD, FACS

Peer Review

IOL Selection for Glaucoma Patients

A review of the pros and cons of premium IOLs in glaucomatous eyes.

Susan Liang, MD, and Sarwat Salim, MD, FACS | Section Editor

Peer Review

Glaucoma Management in Nanophthalmos

Small eyes can present big challenges.

Mohammad Pakravan, MD

Peer Review

Management of Angle-Closure Glaucoma

Appropriate and timely intervention is crucial.

Chandrasekharan Krishnan, MD

Peer Review

Elevated IOP After Laser Treatment

Laser procedures that are ordinarily safe can sometimes have unexpected outcomes.

Frank Cao, MD, and Inci Irak Dersu, MD

Peer Review

Marijuana and Glaucoma

Side effects, health risks, and a short duration of action limit the usefulness of this drug.

Thomas A. Graul, MD

Peer Review

You Say You Want a Revolution

Antivascular endothelial growth factor agents have dramatically changed the early management of neovascular glaucoma.

Mark Slabaugh, MD, and Matthew Ohr, MD

Peer Review

Surgical Management of Traumatic Glaucoma

A stepwise approach.

Omolola O. Idowu, MBChB, MRCS(Ed), and Carla I. Bourne, MD

Peer Review

The Role of Perfusion Pressure

Risk factors other than IOP play a role in the pathogenesis of glaucoma.

Robert N. Weinreb, MD; Jeffrey M. Liebmann, MD; and Louis R. Pasquale, MD

Peer Review

Glaucoma in the Octogenarian

Considerations in treating the advanced elderly.

Samuel P. Solish, MD

Peer Review

Detecting and Treating Glaucoma in a Myopic Patient Without High IOP

Robert Chang, MD, and Kuldev Singh, MD, MPH

Peer Review

Cataract Surgery in High-Risk Glaucoma Patients

Do the risks outweigh the benefits?

Aaron M. Marble, BS; Bradley P. Roth, MS; and Barbara A. Smit, MD, PhD